| scholarly article | Q13442814 |
| P356 | DOI | 10.7326/0003-4819-147-1-200707030-00005 |
| P698 | PubMed publication ID | 17606958 |
| P2093 | author name string | Ashish Kumar | |
| Shiv Kumar Sarin | |||
| Manju Puri | |||
| Shubha Sagar Trivedi | |||
| Sharda Patra | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | human pregnancy | Q11995 |
| pregnant person | Q104720811 | ||
| hepatitis E | Q326643 | ||
| hepatitis E virus | Q5731737 | ||
| maternal health | Q6786626 | ||
| P304 | page(s) | 28-33 | |
| P577 | publication date | 2007-07-01 | |
| P1433 | published in | Annals of Internal Medicine | Q564416 |
| P1476 | title | Maternal and fetal outcomes in pregnant women with acute hepatitis E virus infection | |
| P478 | volume | 147 |
| Q79619304 | A 20-year single-center experience with acute liver failure during pregnancy: is the prognosis really worse? |
| Q90445596 | A 5-year Single-Center Experience of Hepatitis E Virus Infection During Pregnancy |
| Q47549364 | A Cross-Sectional Study of Viral Hepatitis Perception among Residents from Southeast and North Regions of Brazil |
| Q40532962 | A Study of Hepatitis E in Pregnancy: Maternal and Fetal Outcome |
| Q33557621 | A fatal case of acute hepatitis E among pregnant women, Central African Republic |
| Q37197088 | A preliminary cost-effectiveness analysis of hepatitis E vaccination among pregnant women in epidemic regions |
| Q40809932 | ACG Clinical Guideline: Liver Disease and Pregnancy |
| Q47547349 | Acute Hepatitis E Virus Infection in Two Geographical Regions of Nigeria |
| Q39761330 | Acute Liver Failure and Liver Assist Devices |
| Q56430379 | Acute liver failure |
| Q35166178 | Acute liver failure in pregnancy: causative and prognostic factors |
| Q36392245 | Acute risk for hepatitis E virus infection among HIV-1-positive pregnant women in central Africa |
| Q30251421 | Advances in hepatitis E - II: Epidemiology, clinical manifestations, treatment and prevention. |
| Q41923560 | Adverse fetal outcomes in pregnant rabbits experimentally infected with rabbit hepatitis E virus |
| Q45323681 | An ethanol extract of Lysimachia mauritiana exhibits inhibitory activity against hepatitis E virus genotype 3 replication |
| Q37726521 | An outbreak of hepatitis E and high maternal mortality at Port Sudan, Eastern Sudan |
| Q38391136 | An outbreak of hepatitis E in an urban area of Bangladesh. |
| Q90417726 | An outbreak of hepatitis E virus infection caused by genotype 1 in an urban setting in eastern India: a probe into risk factors for transmission |
| Q40507421 | Animal Models for Hepatitis E Virus |
| Q91974412 | Antihepatitis B Surface Antigen and Hepatitis C Antibodies among Pregnant Women in an Urban Area of Mwanza City, Tanzania |
| Q43145214 | Antituberculosis therapy-induced acute liver failure: magnitude, profile, prognosis, and predictors of outcome |
| Q92458456 | Antiviral Candidates for Treating Hepatitis E Virus Infection |
| Q38174398 | Antiviral strategies for hepatitis E virus |
| Q40269137 | Asymptomatic acute hepatitis E in a female patient with ulcerative colitis. |
| Q37630325 | Autochthonous hepatitis e virus infections: a new transfusion-associated risk? |
| Q46335824 | Brief report: acute viral hepatitis and poor maternal and perinatal outcomes in pregnant Sudanese women |
| Q98157702 | Burden of hepatitis E virus infection in pregnancy and maternofoetal outcomes: a systematic review and meta-analysis |
| Q37872195 | Case definition and phenotype standardization in drug-induced liver injury. |
| Q30251843 | Case-fatality risk of pregnant women with acute viral hepatitis type E: a systematic review and meta-analysis |
| Q92826418 | Chronic testicular Chlamydia muridarum infection impairs mouse fertility and offspring development† |
| Q42198637 | Clinical and molecular analyses of sporadic acute hepatitis A and E and the specific viral genotypes isolated in Iwate and three neighboring prefectures in the northern part of Honshu, Japan, between 2004 and 2013. |
| Q45386479 | Clinical course and duration of viremia in vertically transmitted hepatitis E virus (HEV) infection in babies born to HEV-infected mothers |
| Q38207464 | Clinical focus: infections in pregnancy |
| Q37860521 | Clinical presentation of hepatitis E |
| Q91941584 | Clinical presentations of Hepatitis E: A clinical review with representative case histories |
| Q34092748 | Clinical profile, maternal and fetal outcomes of acute hepatitis e in pregnancy |
| Q34158630 | Continuing challenge of infectious diseases in India |
| Q35619141 | Current Status of Hepatitis E Virus Infection in Korea |
| Q92316032 | Detection of Hepatitis E Antibodies in Kazakhstan: A Pilot Study |
| Q34164503 | Discovery of hepatitis E: the epidemic non-A, non-B hepatitis 30 years down the memory lane. |
| Q42280440 | Does high viral load of hepatitis E virus influence the severity and prognosis of acute liver failure during pregnancy? |
| Q34607030 | Epidemiology and associated risk factors of hepatitis e virus infection in plateau state, Nigeria |
| Q40507459 | Epidemiology of Hepatitis E. |
| Q37389167 | Epidemiology of hepatitis E virus in the United States: results from the Third National Health and Nutrition Examination Survey, 1988-1994 |
| Q38076254 | Epidemiology of mammalian hepatitis E virus infection |
| Q57000371 | Estimating the burden of maternal and neonatal deaths associated with jaundice in Bangladesh: possible role of hepatitis E infection |
| Q41246013 | Experimental infection of pregnant rabbits with hepatitis E virus demonstrating high mortality and vertical transmission |
| Q37185912 | Factors influencing occurrence of postpartum haemorrhage in pregnant women with hepatitis E infection and deranged coagulation profile |
| Q34399964 | Fatal hepatitis E viral infection in pregnant women in Ghana: a case series |
| Q37978428 | Fatal outbreaks of jaundice in pregnancy and the epidemic history of hepatitis E |
| Q66679485 | Features of Human Decidual NK Cells in Healthy Pregnancy and During Viral Infection |
| Q37573028 | Fetal and neonatal health consequences of vertically transmitted hepatitis E virus infection |
| Q38119681 | Fulminant Viral Hepatitis |
| Q38946359 | Fulminant hepatic failure from hepatitis E in a non-pregnant female traveller |
| Q33578789 | Fulminant hepatitis E in a woman taking oral contraceptive medication. |
| Q38503516 | Gene Expression Profiles of T Cells from Hepatitis E Virus Infected Patients in Acute and Resolving Phase |
| Q42222333 | Genetic host specificity of hepatitis E virus |
| Q92637187 | Hepatitis E Virus Assembly and Release |
| Q34801927 | Hepatitis E and pregnancy: understanding the pathogenesis |
| Q35849810 | Hepatitis E infection during pregnancy |
| Q36364737 | Hepatitis E virus and fulminant hepatitis--a virus or host-specific pathology? |
| Q26751267 | Hepatitis E virus as an emerging zoonotic pathogen |
| Q92726290 | Hepatitis E virus infection among pregnant women in Africa: systematic review and meta-analysis |
| Q96299192 | Hepatitis E virus infection during pregnancy |
| Q37278809 | Hepatitis E virus infection is highly prevalent among pregnant women in Accra. Ghana |
| Q52699055 | Hepatitis E virus replication and interferon responses in human placental cells. |
| Q79758481 | Hepatitis E-associated acute liver failure in pregnancy: an Indian puzzle |
| Q92144891 | Hepatitis E-related adverse pregnancy outcomes and their prevention by hepatitis E vaccine in a rabbit model |
| Q90093413 | Hepatitis E: What We Think We Know |
| Q37613188 | Hepatitis e and acute liver failure in pregnancy. |
| Q86895930 | Hepatobiliary quiz-8 (2013) |
| Q46329129 | High viral load and deregulation of the progesterone receptor signaling pathway: Association with Hepatitis E-related poor pregnancy outcome |
| Q37544940 | Host immune status and response to hepatitis E virus infection. |
| Q40058105 | Impact of maternal nutrition in hepatitis E infection in pregnancy |
| Q41020103 | Impaired monocyte-macrophage functions and defective Toll-like receptor signaling in hepatitis E virus-infected pregnant women with acute liver failure |
| Q90345636 | In vivo models for studying Hepatitis E virus infection; Updates and applications |
| Q37439907 | Increased risk of hepatotoxicity in HIV-infected pregnant women receiving antiretroviral therapy independent of nevirapine exposure |
| Q92276031 | Indian National Association for the Study of the Liver-Federation of Obstetric and Gynaecological Societies of India Position Statement on Management of Liver Diseases in Pregnancy |
| Q28073697 | Inhibitor-Based Therapeutics for Treatment of Viral Hepatitis |
| Q57097961 | Investigation of an epidemic of Hepatitis E in Nellore in south India |
| Q45337304 | Isolation of Hepatitis E Virus From Breast Milk During Acute Infection |
| Q92092563 | Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission |
| Q59810283 | Liver transplantation for acute liver failure due to hepatitis E in a pregnant patient |
| Q35905989 | Maternal-Fetal Hepatitis E Transmission: Is It Underestimated? |
| Q36910879 | Materno-Fetal Outcomes with Viral Hepatitis in Pregnancy |
| Q34942241 | Molecular biology and pathogenesis of hepatitis E virus |
| Q79621614 | Of pigs and pregnancy |
| Q36644560 | One in Five Maternal Deaths in Bangladesh Associated with Acute Jaundice: Results from a National Maternal Mortality Survey |
| Q34034046 | Outbreak of hepatitis E in urban Bangladesh resulting in maternal and perinatal mortality |
| Q42030589 | Plasma and urine biomarkers in acute viral hepatitis E |
| Q34589499 | Plasma peptidome profiling of acute hepatitis E patients by MALDI-TOF/TOF. |
| Q26827604 | Pregnancy and infection |
| Q27005799 | Pregnancy and susceptibility to infectious diseases |
| Q37265614 | Preventative hepatology: minimising symptoms and optimising care. |
| Q40507392 | Prophylactic Hepatitis E Vaccine |
| Q38699244 | Prophylaxis against hepatitis E: at risk populations and human vaccines. |
| Q90396064 | Raise awareness of the global burden of viral hepatitis & to influence real change |
| Q50021143 | Replication of hepatitis E virus in the ovary and promotion of oocyte apoptosis in rabbits infected with HEV-4. |
| Q47546208 | Sero-prevalence and risk factors for hepatitis E virus infection among pregnant women in the Cape Coast Metropolis, Ghana |
| Q33977156 | Seroepidemiology of a second epidemic of hepatitis E in a population that had recorded first epidemic 30 years before and has been under surveillance since then |
| Q47226182 | Serological and virological survey of hepatitis E virus (HEV) in animal reservoirs from Uruguay reveals elevated prevalences and a very close phylogenetic relationship between swine and human strains. |
| Q40055954 | Seroprevalence and incidence of hepatitis E virus among blood donors: A review |
| Q38398009 | Seroprevalence and incidence of hepatitis E virus infection in German blood donors |
| Q33834743 | Seroprevalence and risk factors of Hepatitis E Virus infection among pregnant women in Addis Ababa, Ethiopia. |
| Q64123995 | Seroprevalence of Hepatitis A and Hepatitis E Viruses among Pregnant Women in Haiti |
| Q36185969 | Seroprevalence of hepatitis E virus differs in Dutch and first generation migrant populations in Amsterdam, the Netherlands: a cross-sectional study |
| Q45353262 | Serum tumor necrosis factor-alpha level in hepatitis E virus-related acute viral hepatitis and fulminant hepatic failure in pregnant women |
| Q33369994 | Subduing the hepatitis E Python |
| Q57792563 | Successful management of a same-day emergency delivery and liver transplant in a 27â weeks pregnant woman with fulminant hepatic failure |
| Q92829439 | Targeted hepatitis E vaccination for women of childbearing age is cost-effective in China |
| Q36455791 | The Association of Cytokines and Micronutrients with Hepatitis E Virus Infection During Pregnancy and the Postpartum Period in Rural Bangladesh |
| Q40059581 | The Enigma of Hepatitis E Virus |
| Q36980637 | The ORF3 Protein of Genotype 1 Hepatitis E Virus Suppresses TLR3-induced NF-κB Signaling via TRADD and RIP1. |
| Q30248393 | The global burden of hepatitis E outbreaks: a systematic review. |
| Q45361424 | The global burden of hepatitis E virus genotypes 1 and 2 in 2005 |
| Q40663054 | The role of hepatitis E virus infection in adult Americans with acute liver failure |
| Q39382358 | The unique immunological and microbial aspects of pregnancy |
| Q40542632 | Transmission of Hepatitis E Virus |
| Q33734018 | Transmission, diagnosis, and management of hepatitis E: an update |
| Q94340226 | UEG Week 2016 Poster Presentations |
| Q36725544 | Variability and pathogenicity of hepatitis E virus genotype 3 variants |
| Q84442607 | Viral Hepatitis in India |
| Q42923174 | Viral hepatitis eradication in India by 2080--gaps, challenges & targets. |
| Q37130825 | Viral hepatitis vaccination during pregnancy |
| Q27027087 | Viral infections during pregnancy |
| Q34589971 | Virus Host Protein Interaction Network Analysis Reveals That the HEV ORF3 Protein May Interrupt the Blood Coagulation Process |
| Q37741610 | miRNA signatures can predict acute liver failure in hepatitis E infected pregnant females |
| Q45825862 | Infection par le virus de l’hépatite E durant la grossesse |
Search more.